No Data
No Data
Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.
"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.
There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.
Cumulative dividends exceed 0.3 billion over 4 years.
Vincent Med (01612.HK) subsidiary passes USA FDA review and receives a 'No Action Indicated' rating.
Vincent Med (01612.HK) announced that its wholly-owned subsidiary, Dongguan Vincent Med Products, recently received a "No Action Indicated" rating following a risk-based work plan review conducted by the Food and Drug Administration (FDA) of the USA. The review was focused on the ventilator manufacturer's tier 2 quality system inspection plan with risk as the main consideration. During the 5-day review, representatives from the FDA examined the operation, production process, and regulations of Dongguan Vincent Med Products, confirming compliance with relevant document requirements and manufacturing standards. Vincent Med Chairman, Cai Wencheng, expressed
VINCENT MED: INTERIM REPORT 2024
Express News | China Securities Co.,Ltd. recommends focusing on investment opportunities in the medical device sector, and focusing on the direction and individual stocks with strong performance certainty.
Express News | China Securities Co., Ltd.: Focus on investment opportunities in the medical devices, high-value consumables, and IVD (in-vitro diagnostic) fields.
No Data
No Data